세계의 동물 바이오테크놀러지 시장 보고서(2025년)

Animal biotechnology involves the application of science and engineering techniques to modify living organisms for the benefit of humans and other animals. This field utilizes genetic engineering to modify the genome of animals, with applications ranging from pharmaceuticals and industrial processes to agriculture.

The main products of animal biotechnology include diagnostics tests, vaccines, drugs, reproductive and genetic technologies, as well as feed additives for animals such as companion and livestock. Diagnostics tests are a set of techniques used to diagnose diseases or conditions in organisms. Animal biotechnology is applied in various areas, including the diagnosis and treatment of animal diseases, preventive care, drug development, and other applications. These products are utilized in laboratories, point-of-care testing (in-house testing), veterinary hospitals and clinics, and other end-use settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The animal biotechnology market research report is one of a series of new reports from The Business Research Company that provides animal biotechnology market statistics, including animal biotechnology industry global market size, regional shares, competitors with an Critical infrastructure protection market share, detailed animal biotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the animal biotechnology industry. This animal biotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The animal biotechnology market size has grown strongly in recent years. It will grow from $30.33 billion in 2024 to $32.89 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to genetic improvement, increased agricultural productivity, vaccines and therapeutics, environmental sustainability, feed efficiency, nutritional enhancement, reduced environmental impact.

The animal biotechnology market size is expected to see rapid growth in the next few years. It will grow to $48.36 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to development of disease-resistant strains, biopharmaceutical production, cell-based meat production, global food security concerns, regulatory support, public and consumer acceptance. Major trends in the forecast period include genome editing technologies, genome editing technologies, animal stem cell technology, biopharmaceutical production in animals, biobanking and genetic resource preservation, emergence of Crispr-based therapies, biosecurity and disease surveillance.

The forecast of 10.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Higher duties on precision lab instruments and CRISPR reagents imported from Germany and Japan threaten to slow animal-gene-editing R&D pipelines and lengthen time-to-market for novel traits. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing awareness of animal health and welfare is anticipated to drive the growth of the animal biotechnology market in the future. Animal health and welfare encompass the interactions between people and animals and the responsibility to ensure that animals are treated properly and compassionately. Within this context, animal biotechnology plays a significant role in enhancing animal productivity by improving growth, reproductive quality, nutrition, feed efficiency, food safety, and other factors, leading to more effective resource utilization. For example, in May 2023, the Humane Society launched the "More Than a Pet" campaign to highlight the importance of equitable access to veterinary care, particularly for underserved communities. Through this initiative, over 14,800 pets received 64,000 services in 2023 via community outreach programs designed to enhance animal welfare in low-resource areas. The campaign emphasizes providing essential veterinary care and support to improve the well-being of animals in these underserved regions. Thus, the rising awareness of animal health and welfare is propelling the growth of the animal biotechnology market.

The expanding livestock population plays a crucial role in propelling the growth of the animal biotechnology sector. Livestock, encompassing domesticated animals raised for agricultural and economic purposes, provides a diverse pool for research and development endeavors within animal biotechnology. The increasing livestock numbers offer researchers a broader spectrum of species to explore, test, and develop new biotechnological solutions. For example, in the UK, there was a recorded rise of 0.3% in the cattle and calves population from 2021 to 2022, amounting to 9.6 million animals. This increase signifies the potential for research and innovation within the animal biotechnology domain, thereby influencing its growth positively.

Within the animal biotechnology market, product innovation stands as a significant trend. Key industry players are heavily invested in developing pioneering goods, such as the employment of virus-like particle (VLP) technology for vaccine development. For instance, in April 2022, Cadila Pharmaceuticals, an India-based multinational pharmaceutical company, introduced ThRabis, a three-dose rabies vaccine prepared using virus-like particle technology. Utilizing recombinant nanoparticle-based rabies G protein, ThRabis(R) is designed to generate antibodies that neutralize the rabies virus and impede its attachment to cells, thereby providing protection against rabies. This approach illustrates a safer and cost-effective vaccine development method that holds promise within the animal biotechnology realm.

Major companies in the animal biotechnology sector are investing in innovative technological solutions, such as the development of the Animal Biotech Resource Page, to bolster their market position. This resource page serves as a comprehensive public library gathering animal biotechnology resources obtained from global workshops. For instance, the International Service for the Acquisition of Agri-biotech Applications (ISAAA), a non-profit organization based in the United States, launched the Animal Biotech Resource Page in June 2023. This platform offers a wide array of materials, including presentation slides, podcasts, videos, and workshop content, covering the latest advancements in the sector and pertinent regulatory strategies. These global forums facilitate discussions and consensus-building on various subjects. The primary objective of the Animal Biotech Resource Page is to provide researchers, regulators, students, and key stakeholders within the animal biotech field with ongoing opportunities for learning and discourse. By fostering a deeper understanding of the technology, this initiative aims to maximize its benefits for both the environment and society.

Zoetis Inc., a US-based pharmaceutical company, made a strategic move in September 2023 by acquiring Adivo, a biotechnology company headquartered in Germany, for an undisclosed amount. This acquisition grants Zoetis access to state-of-the-art species-specific antibody libraries and advanced technological expertise. The integration of Adivo's resources positions Zoetis to develop a wide range of cutting-edge veterinary treatments. With the new capabilities from Adivo, Zoetis aims to address unmet needs in companion animals, particularly in areas like cancer treatment, inflammatory disorders, and others. This strategic acquisition further strengthens Zoetis's position in delivering innovative therapeutic antibodies, catering to the evolving demands of its clientele within the veterinary field.

Major companies operating in the animal biotechnology market are Zoetis Inc., Boehringer Ingelheim International GmbH, Biogenesis Bago SA, Merck & Co Inc., Virbac, Elanco Animal Health Incorporated, Randox Laboratories Ltd., Santa Cruz Biotechnology Inc., IDEXX Laboratories Inc., IDVet, Heska Corporation, INDICAL BIOSCIENCE GmbH, BioChek BV, Ceva Sante Animale, Dalan Animal Health, Vetigenics, Vetoquinol S.A., Neogen Corporation, Abaxis Inc., Henry Schein Animal Health, Patterson Companies Inc., Covetrus Inc., Phibro Animal Health Corporation, Novartis Animal Health, Bayer AG, Bioniche Life Sciences Inc., Bio-Rad Laboratories Inc., Biovet JSC, Bovogen Biologicals Pty Ltd.

North America was the largest region in the animal biotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the animal biotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The animal biotechnology market includes revenues earned by entities by using animal biotechnology for dogs, cats, horses, poultry, swine, cattle, sheep, goats and fish. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Animal Biotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on animal biotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for animal biotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The animal biotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Diagnostics Tests; Vaccines; Drugs; Reproductive And Genetic; Feed Additives
• 2) By Animal Type: Companion; Livestock
• 3) By Application: Diagnosis Of Animal Diseases; Treatment Of Animal Diseases; Preventive Care Of Animals; Drug Development; Other Applications
• 4) By End-Use: Laboratories; Point-Of-Care Testing Or In-house Testing; Veterinary Hospitals And Clinics; Other End-Uses
• Subsegments:
• 1) By Diagnostics Tests: Immunodiagnostic Tests; Molecular Diagnostic Tests; Biochemical Diagnostic Tests
• 2) By Vaccines: Inactivated Vaccines; Live Attenuated Vaccines; Recombinant Vaccines
• 3) By Drugs: Antimicrobial Drugs; Anti-Inflammatory Drugs; Hormonal Drugs
• 4) By Reproductive And Genetic: Genetic Testing Services; Artificial Insemination Products; Embryo Transfer Technologies
• 5) By Feed Additives: Probiotics; Enzymes; Nutraceuticals
• Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim International GmbH; Biogenesis Bago SA; Merck & Co Inc.; Virbac; Elanco Animal Health Incorporated; Randox Laboratories Ltd.; Santa Cruz Biotechnology Inc.; IDEXX Laboratories Inc.; IDVet; Heska Corporation; INDICAL BIOSCIENCE GmbH; BioChek BV; Ceva Sante Animale; Dalan Animal Health; Vetigenics; Vetoquinol S.A.; Neogen Corporation; Abaxis Inc.; Henry Schein Animal Health; Patterson Companies Inc.; Covetrus Inc.; Phibro Animal Health Corporation; Novartis Animal Health; Bayer AG; Bioniche Life Sciences Inc.; Bio-Rad Laboratories Inc.; Biovet JSC; Bovogen Biologicals Pty Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Animal Biotechnology Market Characteristics

3. Animal Biotechnology Market Trends And Strategies

4. Animal Biotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Animal Biotechnology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Animal Biotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Animal Biotechnology Market Growth Rate Analysis
• 5.4. Global Animal Biotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Animal Biotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Animal Biotechnology Total Addressable Market (TAM)

6. Animal Biotechnology Market Segmentation

• 6.1. Global Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics Tests
• Vaccines
• Drugs
• Reproductive And Genetic
• Feed Additives
• 6.2. Global Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Companion
• Livestock
• 6.3. Global Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnosis Of Animal Diseases
• Treatment Of Animal Diseases
• Preventive Care Of Animals
• Drug Development
• Other Applications
• 6.4. Global Animal Biotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratories
• Point-Of-Care Testing/In-house Testing
• Veterinary Hospitals And Clinics
• Other End-Uses
• 6.5. Global Animal Biotechnology Market, Sub-Segmentation Of Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunodiagnostic Tests
• Molecular Diagnostic Tests
• Biochemical Diagnostic Tests
• 6.6. Global Animal Biotechnology Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• 6.7. Global Animal Biotechnology Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antimicrobial Drugs
• Anti-Inflammatory Drugs
• Hormonal Drugs
• 6.8. Global Animal Biotechnology Market, Sub-Segmentation Of Reproductive and Genetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing Services
• Artificial Insemination Products
• Embryo Transfer Technologies
• 6.9. Global Animal Biotechnology Market, Sub-Segmentation Of Feed Additives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Probiotics
• Enzymes
• Nutraceuticals

7. Animal Biotechnology Market Regional And Country Analysis

• 7.1. Global Animal Biotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Animal Biotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Animal Biotechnology Market

• 8.1. Asia-Pacific Animal Biotechnology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Animal Biotechnology Market

• 9.1. China Animal Biotechnology Market Overview
• 9.2. China Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Animal Biotechnology Market

• 10.1. India Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Animal Biotechnology Market

• 11.1. Japan Animal Biotechnology Market Overview
• 11.2. Japan Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Animal Biotechnology Market

• 12.1. Australia Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Animal Biotechnology Market

• 13.1. Indonesia Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Animal Biotechnology Market

• 14.1. South Korea Animal Biotechnology Market Overview
• 14.2. South Korea Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Animal Biotechnology Market

• 15.1. Western Europe Animal Biotechnology Market Overview
• 15.2. Western Europe Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Animal Biotechnology Market

• 16.1. UK Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Animal Biotechnology Market

• 17.1. Germany Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Animal Biotechnology Market

• 18.1. France Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Animal Biotechnology Market

• 19.1. Italy Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Animal Biotechnology Market

• 20.1. Spain Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Animal Biotechnology Market

• 21.1. Eastern Europe Animal Biotechnology Market Overview
• 21.2. Eastern Europe Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Animal Biotechnology Market

• 22.1. Russia Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Animal Biotechnology Market

• 23.1. North America Animal Biotechnology Market Overview
• 23.2. North America Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Animal Biotechnology Market

• 24.1. USA Animal Biotechnology Market Overview
• 24.2. USA Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Animal Biotechnology Market

• 25.1. Canada Animal Biotechnology Market Overview
• 25.2. Canada Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Animal Biotechnology Market

• 26.1. South America Animal Biotechnology Market Overview
• 26.2. South America Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Animal Biotechnology Market

• 27.1. Brazil Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Animal Biotechnology Market

• 28.1. Middle East Animal Biotechnology Market Overview
• 28.2. Middle East Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Animal Biotechnology Market

• 29.1. Africa Animal Biotechnology Market Overview
• 29.2. Africa Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Animal Biotechnology Market Competitive Landscape And Company Profiles

• 30.1. Animal Biotechnology Market Competitive Landscape
• 30.2. Animal Biotechnology Market Company Profiles
  • 30.2.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Biogenesis Bago SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Virbac Overview, Products and Services, Strategy and Financial Analysis

31. Animal Biotechnology Market Other Major And Innovative Companies

• 31.1. Elanco Animal Health Incorporated
• 31.2. Randox Laboratories Ltd.
• 31.3. Santa Cruz Biotechnology Inc.
• 31.4. IDEXX Laboratories Inc.
• 31.5. IDVet
• 31.6. Heska Corporation
• 31.7. INDICAL BIOSCIENCE GmbH
• 31.8. BioChek BV
• 31.9. Ceva Sante Animale
• 31.10. Dalan Animal Health
• 31.11. Vetigenics
• 31.12. Vetoquinol S.A.
• 31.13. Neogen Corporation
• 31.14. Abaxis Inc.
• 31.15. Henry Schein Animal Health

32. Global Animal Biotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Animal Biotechnology Market

34. Recent Developments In The Animal Biotechnology Market

35. Animal Biotechnology Market High Potential Countries, Segments and Strategies

• 35.1 Animal Biotechnology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Animal Biotechnology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Animal Biotechnology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer